Kimia Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 24.43 | 38.69 | 30.52 |
| Operating Expense | 21.06 | 30.06 | 25.10 |
| Net Profit | 0.60 | 1.99 | 4.57 |
| Net Profit Margin | 2.46 | 5.14 | 14.97 |
| Earning Per Share | 0.13 | 0.42 | 0.97 |
| EBIDTA | 3.29 | 4.27 | 5.78 |
| Effective Tax Rate | TBA | TBA | -11.44 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 24.43 |
| Operating Expense | 21.06 |
| Net Profit | 0.60 |
| Net Profit Margin | 2.46 |
| Earning Per Share | 0.13 |
| EBIDTA | 3.29 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 118.92 | 104.88 | 128.52 |
| Operating Expenses Annual | 98.67 | 105.36 | 133.49 |
| Operating Profit Annual | 21.57 | 1.16 | -4.81 |
| Interest Annual | 4.56 | 5.05 | 4.25 |
| Depreciation | 3.36 | 3.24 | 3.27 |
| Net Profit Annual | 9.61 | -5.31 | -9.35 |
| Tax Annual | 4.02 | -1.88 | -3.04 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 118.92 |
| Operating Expenses Annual | 98.67 |
| Operating Profit Annual | 21.57 |
| Interest Annual | 4.56 |
| Depreciation | 3.36 |
| Net Profit Annual | 9.61 |
| Tax Annual | 4.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.15 | 0.18 | 0.20 |
| Cash Flow from Operations | 21.31 | 14.53 | -6.77 |
| Cash Flow from Investing | -4.70 | -1.49 | -2.80 |
| Cash Flow from Financing | -16.55 | -13.07 | 9.54 |
| Cash Flow at the End | 0.21 | 0.15 | 0.18 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.15 |
| Cash Flow from Operations | 21.31 |
| Cash Flow from Investing | -4.70 |
| Cash Flow from Financing | -16.55 |
| Cash Flow at the End | 0.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 18.14 | 1.11 | -3.74 |
| PBIT Margin (%) | 15.30 | -2.03 | -6.33 |
| PBT Margin (%) | 11.94 | -1.63 | -4.84 |
| Net PROFIT Margin (%) | 8.08 | -5.06 | -7.28 |
| Return On Networth / Equity (%) | 172.53 | TBA | TBA |
| Return On Networth /Employed (%) | 34.57 | TBA | TBA |
| Return On Assets (%) | 18.42 | -8.86 | -14.26 |
| Total Debt / Equity (X) | 7.46 | 16.69 | 4.60 |
| Asset Turnover Ratio (%) | 2.28 | 1.75 | 1.96 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 18.14 |
| PBIT Margin (%) | 15.30 |
| PBT Margin (%) | 11.94 |
| Net PROFIT Margin (%) | 8.08 |
| Return On Networth / Equity (%) | 172.53 |
| Return On Networth /Employed (%) | 34.57 |
| Return On Assets (%) | 18.42 |
| Total Debt / Equity (X) | 7.46 |
| Asset Turnover Ratio (%) | 2.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 33.28 | 31.85 | 33.63 |
| Total Current Assets Annual | 75.29 | 61.41 | 82.75 |
| Non Current Assets Annual | 35.92 | 38.56 | 38.57 |
| Total Shareholders Funds Annual | 9.97 | 0.33 | 5.46 |
| Total Assets Annual | 111.21 | 99.97 | 121.32 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 33.28 |
| Total Current Assets Annual | 75.29 |
| Non Current Assets Annual | 35.92 |
| Total Shareholders Funds Annual | 9.97 |
| Total Assets Annual | 111.21 |
No Data Availabe
